Kura Oncology Inc (KURA)
17.96
+0.14
(+0.79%)
USD |
NASDAQ |
Nov 05, 09:38
Kura Oncology Market Cap: 1.376B for Nov. 5, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 04, 2024 | 1.366B |
| November 01, 2024 | 1.294B |
| October 31, 2024 | 1.281B |
| October 30, 2024 | 1.300B |
| October 29, 2024 | 1.330B |
| October 28, 2024 | 1.359B |
| October 25, 2024 | 1.342B |
| October 24, 2024 | 1.363B |
| October 23, 2024 | 1.304B |
| October 22, 2024 | 1.331B |
| October 21, 2024 | 1.356B |
| October 18, 2024 | 1.379B |
| October 17, 2024 | 1.386B |
| October 16, 2024 | 1.400B |
| October 15, 2024 | 1.396B |
| October 14, 2024 | 1.384B |
| October 11, 2024 | 1.424B |
| October 10, 2024 | 1.398B |
| October 09, 2024 | 1.404B |
| October 08, 2024 | 1.392B |
| October 07, 2024 | 1.371B |
| October 04, 2024 | 1.382B |
| October 03, 2024 | 1.393B |
| October 02, 2024 | 1.418B |
| October 01, 2024 | 1.472B |
| Date | Value |
|---|---|
| September 30, 2024 | 1.497B |
| September 27, 2024 | 1.496B |
| September 26, 2024 | 1.491B |
| September 25, 2024 | 1.500B |
| September 24, 2024 | 1.519B |
| September 23, 2024 | 1.549B |
| September 20, 2024 | 1.605B |
| September 19, 2024 | 1.615B |
| September 18, 2024 | 1.553B |
| September 17, 2024 | 1.545B |
| September 16, 2024 | 1.599B |
| September 13, 2024 | 1.600B |
| September 12, 2024 | 1.524B |
| September 11, 2024 | 1.523B |
| September 10, 2024 | 1.513B |
| September 09, 2024 | 1.499B |
| September 06, 2024 | 1.478B |
| September 05, 2024 | 1.508B |
| September 04, 2024 | 1.520B |
| September 03, 2024 | 1.549B |
| August 30, 2024 | 1.614B |
| August 29, 2024 | 1.572B |
| August 28, 2024 | 1.543B |
| August 27, 2024 | 1.554B |
| August 26, 2024 | 1.574B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
293.01M
Minimum
Mar 18 2020
2.748B
Maximum
Dec 11 2020
1.165B
Average
1.042B
Median
Apr 12 2022
Market Cap Benchmarks
| AIM ImmunoTech Inc | 16.27M |
| Perspective Therapeutics Inc | 807.78M |
| Protalix BioTherapeutics Inc | 95.61M |
| Electromed Inc | 196.71M |
| Armata Pharmaceuticals Inc | 85.03M |
Market Cap Related Metrics
| Price to Book Value | 2.953 |
| Price | 17.96 |
| Earnings Yield | -12.42% |